Targeting IL-6 trans-signalling: past, present and future prospects

S Rose-John, BJ Jenkins, C Garbers, JM Moll… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-6 (IL-6) is a key immunomodulatory cytokine that affects the
pathogenesis of diverse diseases, including autoimmune diseases, chronic inflammatory …

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

C Xue, Q Yao, X Gu, Q Shi, X Yuan, Q Chu… - Signal transduction and …, 2023 - nature.com
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway
is an evolutionarily conserved mechanism of transmembrane signal transduction that …

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

C Schultheiß, E Willscher, L Paschold, C Gottschick… - Cell Reports …, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …

Malignancy-associated haemophagocytic lymphohistiocytosis

A Setiadi, A Zoref-Lorenz, CY Lee, MB Jordan… - The Lancet …, 2022 - thelancet.com
Haemophagocytic lymphohistiocytosis (HLH) is an inflammatory syndrome that can occur
with cancer (malignancy-associated HLH) or with immune-activating therapies for cancer …

Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization

T Mizutani, A Ishizaka, M Koga, K Ikeuchi… - Microbiology …, 2022 - journals.asm.org
The role of the intestinal microbiota in coronavirus disease 2019 (COVID-19) is being
elucidated. Here, we analyzed the temporal changes in microbiota composition and the …

Defining the role of anti-and pro-inflammatory outcomes of interleukin-6 in mental health

M García-Juárez, A Camacho-Morales - Neuroscience, 2022 - Elsevier
Abstract Interleukin-6 (IL-6) is a major cytokine that promotes anti-and pro-inflammatory
outcomes by activating the membrane IL-6 receptor (IL-6R) or the soluble IL-6 receptor (sIL …

Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies

S Luo, Y Liang, THT Wong… - International journal …, 2022 - academic.oup.com
Background To summarize modifiable factors for coronavirus disease 2019 (COVID-19)
suggested by Mendelian randomization studies. Methods In this systematic review, we …

Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2-infected mice and reduces endotheliopathy

MÁ Rodríguez-Hernández, M Baena-Bustos… - …, 2024 - thelancet.com
Background SARS-CoV-2 infection is considered as a relapsing inflammatory process with a
dysregulation of IL-6 signalling. Classic IL-6 signalling is thought to represent a defence …

[HTML][HTML] HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

A Tamayo-Velasco, P Martinez-Paz… - Journal of clinical …, 2021 - mdpi.com
Pneumonia is the leading cause of hospital admission and mortality in coronavirus disease
2019 (COVID-19). We aimed to identify the cytokines responsible for lung damage and …

Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19

X **g, M Xu, D Song, T Yue, Y Wang, P Zhang… - Immunity & …, 2022 - Springer
Background COVID-19 patients may experience “cytokine storm” when human immune
system produces excessive cytokines/chemokines. However, it remains unclear whether …